2021
DOI: 10.1080/03639045.2021.1908332
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic and pharmacodynamic studies of iloperidone-loaded lipid nanoemulsions via oral route of administration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 27 publications
0
2
0
Order By: Relevance
“…Iloperidone is another atypical antipsychotic drug that acts as an antagonist for both dopamine D2 and serotonin 5-HT2 receptors, having been approved for schizophrenia treatment by the FDA in 2009. It is available as oral tablets, but extensive first-pass metabolism leads to low bioavailability, and it also has poor water solubility (predictably 0.0304 mg/mL) [ 30 , 50 ]. To help solve these issues, Narala et al developed an O/W nanoemulsion, for oral administration, containing soybean oil (Lipoid), egg lecithin (egg phosphatidyl choline, EPC80), cholesterol, oleic acid, glycerol and water (detailed quantities in Table 6 ).…”
Section: Nanometric Emulsions Containing Antipsychotic Drugsmentioning
confidence: 99%
“…Iloperidone is another atypical antipsychotic drug that acts as an antagonist for both dopamine D2 and serotonin 5-HT2 receptors, having been approved for schizophrenia treatment by the FDA in 2009. It is available as oral tablets, but extensive first-pass metabolism leads to low bioavailability, and it also has poor water solubility (predictably 0.0304 mg/mL) [ 30 , 50 ]. To help solve these issues, Narala et al developed an O/W nanoemulsion, for oral administration, containing soybean oil (Lipoid), egg lecithin (egg phosphatidyl choline, EPC80), cholesterol, oleic acid, glycerol and water (detailed quantities in Table 6 ).…”
Section: Nanometric Emulsions Containing Antipsychotic Drugsmentioning
confidence: 99%
“…Innovative formulation platforms and tactics for novel oral drug delivery technologies are rapidly being developed to address this issue and increase therapeutic efficacy and safety 5,6 . The range of nano-systems in the oral drug delivery area includes liposomes 7,8 , solid lipid nanoparticles 9,10 , nanocrystals [11][12][13] , liposomes 8,14 , polymeric nanoparticles [15][16][17] which are obtained via specialized techniques such as high pressure homogenizer (HPH) 18,19 . Typically, nano-systems exhibits stability issues caused by agglomeration 20 .…”
Section: Introductionmentioning
confidence: 99%